Ten-year risk prediction in French men using the Framingham coronary score: results from the national SU.VI.MAX cohort (Q44509968)

3 December 2017

Ten-year risk prediction in French men using the Framingham coronary score: results from the national SU.VI.MAX cohort (English)

1 reference

3 December 2017

A-C Vergnaud

1

1 reference

3 December 2017

S Bertrais

2

1 reference

3 December 2017

P Galan

3

1 reference

3 December 2017

S Hercberg

4

1 reference

3 December 2017

S Czernichow

5

1 reference

3 December 2017

language of work or name

English

0 references

publication date

10 March 2008

1 reference

3 December 2017

1 reference

3 December 2017

47

1 reference

3 December 2017

1

1 reference

3 December 2017

61-65

1 reference

An updated coronary risk profile. A statement for health professionals.

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.023

The Framingham prediction rule is not valid in a European population of treated hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.023

Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.023

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.023

Use and misuse of the receiver operating characteristic curve in risk prediction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.023

A comparison of the PROCAM and Framingham point-scoring systems for estimation of individual risk of coronary heart disease in the Second Northwick Park Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.023

Prediction of first coronary events with the Framingham score: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.023

Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.023

Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.023

Framingham risk function overestimates risk of coronary heart disease in men and women from Germany—results from the MONICA Augsburg and the PROCAM cohorts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.023

The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.023

A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study--design, methods, and participant characteristics. SUpplementation en VItamin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.023

21 year trends in incidence of myocardial infarction and mortality from coronary disease in middle-age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.023

Updated risk factor values and the ability of the multivariable risk score to predict coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.023

The seven countries study: 2,289 deaths in 15 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.023

Trends and geographical disparities in coronary heart disease in France: are results concordant when different definitions of events are used?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.023

Estimation of CHD risk in a French working population using a modified Framingham model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.023

Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.023

Cardiovascular disease risk assessment in older women: can we improve on Framingham? British Women's Heart and Health prospective cohort study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.023

Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: the Minnesota heart survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.023

Comparison of multivariate predictive power of major risk factors for coronary heart diseases in different countries: results from eight nations of the Seven Countries Study, 25-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.023

Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.023

Mortality by cause for eight regions of the world: Global Burden of Disease Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.023

Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.023

The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.023

Inflammatory markers and long-term risk of ischemic heart disease in men A 13-year follow-up of the Quebec Cardiovascular Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.023

A cross-validation of risk-scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.023

By neglecting deprivation, cardiovascular risk scoring will exacerbate social gradients in disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.023

Alcohol consumption and insulin resistance syndrome parameters: associations and evolutions in a longitudinal analysis of the French DESIR cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.023

CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: ability of inflammatory markers to predict disease in asymptomatic patients: a background paper.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.023

Prediction of Coronary Heart Disease Using Risk Factor Categories

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.023

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2008.02.023

10.1016/J.YPMED.2008.02.023

7 January 2021

Identifiers

DOI

1 reference

3 December 2017

1 reference